Lowering Blood Pressure in Primary Care in Vienna

PHASE4CompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 30, 2017

Study Completion Date

May 30, 2017

Conditions
Hypertension
Interventions
DRUG

Olmesartan medoxomil, amlodipine, hydrochlorothiazide

Up-titration of antihypertensive therapy with single pill combinations (comprising an angiotensin receptor blocker, calcium channel blocker and hydrochlorothiazide) in 4-week intervals if the target blood pressure of \< 140/90 mmHg is not reached at the respective follow-up

Trial Locations (1)

Unknown

GP practices, Vienna

All Listed Sponsors
collaborator

Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology

OTHER

collaborator

Ludwig Boltzmann Foundation for Cardiovascular Research

UNKNOWN

lead

Wilhelminenspital Vienna

OTHER

NCT02377661 - Lowering Blood Pressure in Primary Care in Vienna | Biotech Hunter | Biotech Hunter